Spectrum Pharmaceuticals, Inc.

NASDAQ:SPPI  
3.48
+0.42 (+13.72%)
4:29:17 PM EDT: $3.40 -0.08 (-2.30%)
Other Pre-Announcement

Spectrum Pharmaceuticals Reports Fourth Quarter 2020 And Full Year 2020 Financial Results

Published: 03/30/2021 20:20 GMT
Spectrum Pharmaceuticals, Inc. (SPPI) - Spectrum Pharmaceuticals Reports Fourth Quarter 2020 and Full Year 2020 Financial Results and Pipeline Update.
Q4 Non-GAAP Loss per Share $0.20.
Q4 Loss per Share $0.36.
Q4 Earnings per Share Estimate $-0.29 -- Refinitiv Ibes Data (analyst estimates).
Says Poziotinib Receives Fast Track Designation From FDA.
Says Cash, Cash Equivalents, and Marketable Securities of Approximately $180.0 Million As of December 31, 2020.